MedPath

Understanding and Predicting Breast Cancer Events After Treatment

Not Applicable
Active, not recruiting
Conditions
Breast Cancer
Registration Number
NCT02791581
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

This study is being done to see if patients receiving chemotherapy for breast cancer affects the heart, the ability to exercise and fatigue when compared to patients who do not have cancer.

Detailed Description

840 women aged ≥18 years old scheduled to receive chemotherapy for Stage I-III breast cancer and a comparison population of 160 women without cancer (1,000 total). Equal numbers of women will be recruited aged \< 52 vs. \> 52. At baseline, innovative MRI measures of CV function (LV and aorta); measurements of submaximal (6-minute walk) and, on 45% of the cohort, maximal (peak VO2) exercise capacity; questionnaire data to assess fatigue and behavioral and psychosocial risk factors; and biomarkers will be collected.

Measurements will be repeated at 3±1, 12±2 and 24±2 months. This study will assess the relevance of pre-existing factors such as age, black/white race, hypertension, smoking (yes/no), diabetes, coronary artery disease, menopause status, CV medications, and physical activity on the study outcomes. Also, this study will assess dynamic change in modifiable CV risk factors (including BMI, blood pressure, serum lipids, serum glucose, physical activity, psychosocial factors, lifestyle behaviors), and the cancer treatment including chemotherapy, radiation therapy, immunotherapy, and surgery.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
403
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in FACT-Fatigue ResultsBaseline, 3 months, 12 months and 24 months

Participants rate the degree to which each item applies in the past 7 days using a 5-point scale. Scores range from 0-52, with higher scores indicating greater fatigue.

Change in 6 Minute Walk ResultsBaseline, 3 months, 12 months and 24 months

The purpose of this test is to find out how far the participant can walk in 6 minutes.

FACT-FatigueBaseline

Participants rate the degree to which each item applies in the past 7 days prior to Baseline using a 5-point scale. Scores range from 0-52, with higher scores indicating greater fatigue.

Change in MRI Exam ResultsBaseline, 3 months and 24 months

The exam will measure left ventricular volumes, ejection fraction, myocardial strain/strain rate, mass, mapping, aortic pulse wave velocity and aortic wall thickness. The exam will take 10 - 15 minutes to complete.

Secondary Outcome Measures
NameTimeMethod
6 Minute Walk ResultsBaseline, 3 months, 12 months and 24 months

The purpose of this test is to find out how far the participant can walk in 6 minutes.

RAND MOS 36-item Short Form Health Survey (SF-36)Baseline, 3 months, 12 months and 24 months

SF-36 consists of 36 items measuring the following 8 domains: physical function, role limitations due to physical health problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional health problems, and mental health. These 8 domains also provide two summary scores.

Cook-Medley Hostility ScaleBaseline

A 14-item scale used to assess the effect of hostility associated with cardiovascular risk factors.

Minimum Score: 0 Maximum Score: 13 Higher values indicate greater hostility.

PACE Adult Sedentary Behaviors SurveyBaseline, 3 months, 12 months and 24 months

Assess sedentary lifestyle behaviors

Cohen's 4-item Perceived Stress Scale (PSS)Baseline, 3 months, 12 months, and 24 months

A summed scale asking how often over the prior two weeks four aspects of stress were experienced (1=never to 5=very often)

o weeks four aspects of stress were experienced (1=never to 5=very often)

Walking Efficacy for Duration ScaleBaseline, 3 months, 12 months and 24 months

Comprised of six items and will be included as a measure of exercise capacity

Standing Balance TestBaseline, 3 months, 12 months and 24 months

Participants will be asked to maintain balance for up to 30 seconds in three positions characterized by a progressive narrowing of the base support.

Godin Leisure-Time Exercise Questionnaire (LTEQ)Baseline, 3 months, 12 months and 24 months

Main process measure of physical activity participation

KCCQ-12 QuestionnaireBaseline, 24 months

Independently measures the patient's perception of their health status which includes heart failure symptoms (frequency and burden), physical and social limitations, and how their heart failure impacts their QOL within a 2-week recall period.

Changes in FACT-Fatigue ResultsBaseline, 3 months, 12 months, and 24 months

Participants rate the degree to which each item applies in the past 7 days using a 5-point scale. Scores range from 0-52, with higher scores indicating greater fatigue.

Center for Epidemiological Studies Depression Scale (CESD-10)Baseline, 3 months, 12 months and 24 months

Screening questionnaire assessing depressive symptoms during the last week

PROMIS Short Form 8A Measure of Sleep DisturbanceBaseline, 3 months, 12 months and 24 months

Assess time course and risk factors associated with sleep disturbance and fatigue

Minimum Score: Raw: 8, T-score: 28.9 Maximum Score: Raw: 40, T-score: 76.5 Higher values represent greater sleep disturbance.

Chair Stands - Measures Leg StrengthBaseline, 3 months, 12 months and 24 months

Participants will be first asked to stand from a sitting position without using their arms. If they can perform the task, they will then be asked to stand up and sit down five times as quickly as possible. The time to complete the task will be recorded.

Grip StrengthBaseline, 3 months, 12 months and 24 months

Grip strength is assessed with an isometric handgrip dynamometer while the participant is sitting with the head facing straight ahead. The elbow should be bent at a 90 degree angle and the wrist should be at the mid-prone position.

PROMIS Applied Cognitive Abilities Short Form 8A and Applied Cognition General Concerns Short Form 8ABaseline, 3 months, 12 months and 24 months

Measurement of different aspects of cognitive functioning.

PROMIS Applied Cognitive Abilities Short Form 8A

- Minimum Score: Raw: 8, T-score: 27.0 Maximum Score: Raw: 40, T-score: 64.8 Higher values represent better cognition.

Applied Cognition General Concerns Short Form 8A

- Minimum Score: Raw: 8, T-score: 23.3 Maximum Score: Raw: 40, T-score: 62.7 Higher values represent better cognition.

Range of MotionBaseline, 3 months, 12 months and 24 months

Range of motion at the shoulder joint will be assessed with shoulder flexion and shoulder abduction with a goniometer.

Gait Speed TestBaseline, 3 months, 12 months and 24 months

Participants will be instructed to start at a marked walking course with toes touching the start line and when cued to start, will begin walking at their ususal speed. The time to walk from the starting line to the end of the 4-meter walk will be recorded.

Trial Locations

Locations (66)

University of Alabama at Birmingham Cancer Center

🇺🇸

Birmingham, Alabama, United States

MedStar Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

Moffitt Cancer Center - McKinley Campus

🇺🇸

Tampa, Florida, United States

Moffitt Cancer Center

🇺🇸

Tampa, Florida, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

IU Health North Hospital

🇺🇸

Carmel, Indiana, United States

Indiana University/Melvin and Bren Simon Cancer Center

🇺🇸

Indianapolis, Indiana, United States

Springmill Medical Center

🇺🇸

Indianapolis, Indiana, United States

University of Kansas Cancer Center

🇺🇸

Kansas City, Kansas, United States

University of Kansas Hospital-Westwood Cancer Center

🇺🇸

Westwood, Kansas, United States

Scroll for more (56 remaining)
University of Alabama at Birmingham Cancer Center
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.